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1INTRODUCTION
Portal Hypertension causes Gastrointestinal Bleeding .It is most
frequently due to Gastro Esophageal varices (65-70%) and isolated
Gastric varices (10-15%).
Endoscopic therapy(1)
Endoscopic therapy is the only treatment modality that is widely
accepted for the prevention of variceal bleeding, control of acute variceal
bleeding, and prevention of variceal rebleeding. Endoscopic Variceal
therapy includes Variceal  Sclerotherapy and  Variceal Band Ligation.
SCLEROTHERAPY
The technique involves injection of a sclerosant into (intravariceal)
or adjacent to (paravariceal) a varix. Some paravariceal injection usually
takes place during attempted intravariceal therapy. The sclerosants used
include sodium tetradecyl sulfate, sodium morrhuate, ethanolamine
oleate, and absolute alcohol.
COMPLICATIONS OF ENDOSCOPIC VARICEAL THERAPY
During Procedure
Aspiration pneumonia
Retrosternal chest pain
2Following  Procedure
Bleeding
Esophageal dysmotility
Esophageal stricture
Local ulcers
Mediastinitis
Perforation
Systemic (Usually with Sclerotherapy)
Mesenteric venous thrombosis
Pulmonary embolism
Sepsis
Variceal Band Ligation
Endoscopic variceal ligation is the preferred endoscopic modality
for control of acute Esophageal variceal bleeding and prevention of
rebleeding, however, the utility of band ligation in the treatment of gastric
varices is limited. Variceal ligation is simpler to perform than injection
Sclerotherapy. The procedure involves suctioning of the varix into the
channel of an endoscope and deploying a band around the varix. The
band strangulates the varix, thereby causing thrombosis. Multi-band
3devices can be used to apply several bands without requiring withdrawal
and reinsertion of the endoscope. Varices at the Gastroesophageal
junction are banded initially, and then more proximal varices are banded
in a spiral manner at intervals of approximately 2 cm the endoscope is
then withdrawn. Varices in the mid-or proximal Esophagus do not need to
be banded. Endoscopic Variceal Ligation is associated with fewer
complications than sclerotherapy and requires fewer sessions to achieve
Variceal obliteration.
Endoscopic Variceal Ligation can cause local complications,
including Esophageal ulcers strictures, and Dysmotility, albeit less
frequently than does Sclerotherapy. Banding-induced ulcers can be large
and potentially serious if gastric Fundal Varices are banded.
The incidence of treatment-related complications associated with
Endoscopic Ligation was significantly lower than that associated with
Sclerotherapy. The incidence and type of complications in the current
group of patients undergoing Sclerotherapy were similar to those
described in previous reports. Half the complications were Esophageal
strictures without apparent long-term sequelae. (2)
The management of Variceal bleeding remains a clinical challenge
with a high mortality. Despite improvement in therapy there is six week
mortality of atleast 20%.  Although the overall survival rate has improved
in recent years mortality is still closely related to failure to control the
4initial bleeding or early rebleeding, which  occurs in up to 30-40% of
patients within the first 5 days after the initial bleeding episode(3)
Survival in Patients with Cirrhosis and Bleeding Escophageal
Varices Treated with Endoscopic Sclerotherapy or Endoscopic  Ligation.
5Survival in Patients with Cirrhosis and Bleeding Esophageal
Varices Treated with Endoscopic Sclerotherapy or endoscopic Ligation
According to Severity of Liver Disease (Child-Pugh Class)
Endoscopy therapy is widely used for treatment of Variceal
bleeding.
Endoscopy Variceal Banding and Sclerotherapy are the first line
therapies for bleeding Variceal bleeding.
Endoscopic Sclerotherapy has ben proved effective in control of
acute bleeding and decreases the 42 day mortality and is also effective in
preventing Variceal re bleeding .(4)
The complication rates are less in EVL when compared with
Endoscopic Variceal  Sclerotherapy.(5)
Dysmotility of the Esophagus can occur following both
Endoscopic Variceal Band Ligation as well as Endoscopic Sclerotherapy.
Dysmotility of the Esophagus whether they are symptomatic
causing  dysphagia is still a speculation
Whether these motility changes are reversible or progressive to
affect the motor function of the Esophagus.?
With these questions in mind a Reveiw of literature was done.
6ESOPHAGEAL MANOMETRY
Manometric techniques have improved in a stepwise fashion from
a single pressure channel to the development of high resolution
manometry(HRM) with upto 36 pressure sensors.
Evolution of Manometry techniques
1883 Kronecher and Meltzer used air-filled baloons connected to a
manometer,(6)
1940 by Ingelfinger and Abbott  used water filled balloons .(7)
1967 Winans and Harris introduced perfused tubes(9)
1977 Finally Arndorfer introduced capillary infusion system
Use of computer in this field has revolutionized the diagnostic
accuracy and reproducibility of the results.
It has also made the procedure user friendly especially in terms of
calculating results
Advancement in the computer processing allow pressure data to be
presented in real time as a compact ,visually intuitive spatiotemporal plot
of Esophageal pressure activity.
7Spatio-temporal plots provide objective measurements of the forces
that move food and fluid from the pharynx to the stomach and determine
the risk of reflux events.
High resolution manometry
The foundations of HRM were laid in the early 1990 s by Clouse
and Staiano.(10)
Pressure activity is assessed for several swallows at closely spaced
positions through the Esophagus.
Time, catheter position and average pressure are then reconstructed
into pseudo-3D  "topographic plots" that demonstrated the functional
anatomy of the Esophagus(11)
High resolution manometers use micro manometers water perfused
assemblies with 21-32 channels.(13, 14)
More recently solid state catheters with up to 36 pressure sensors
have been devised.
HRM reveals the dynamic action of the upper Esophageal sphincter
the segmental character of Esophageal peristalsis and the functional
anatomy of the Esophago-gastric junction.
8Spatiotemporal plots constructed from data acquired by closely
spaced pressure sensors (<2cms) provide an accurate representation of the
relationship between closure force (contractile pressure), clearance force
(intrabolus pressure )and outflow resistance (nadir pressure and pressure
gradient across the Esophagogastric junction.(15, 16, 17)
The pattern of Esophageal peristalsis and sphincter activity defines
whether Esophageal motor activity is normal or abnormal.
The intra bolus pressure and Esophago-gastric pressure gradient
define whether or not this activity is consistent with effective function.
Spatiotemporal plots of pressure information make it easy to
identify normal and abnormal patterns of Esophageal motility (44).
The advantage of HRM is identification of focal dysmotility
limited to a short segment of Esophagus which might have been missed
by Conventional Manometry.43
Description of the Equipment:
Equipment:
Solid catheter probe system
Water perfusion manometric system
9Water perfusion Manometric systems include
Water perfused catheter
Hydraulic infusion pump
External transducer
Computer with dataware for analysis.
Water perfused polyvinylchloride catheter
The diameter of the catheter is 4 mm, containing 16 capillary
lumens within the catheter of approximately 0.8 mm in diameter and has
side openings 0.8 mm in diameter around a central lumen.
Each of the eight capillary tubes has an opening at a set point along
its length.
These are used for assessment of pressures in the body of the
oesophagus.
The other end of the catheter consists of 16 individual capillary
tubes.
Each capillary tube is marked for identification and ending with a
special tip for connection to the external transducers, set on a rack at the
same level as the subject's oesophagus in the supine position and are
connected to both the hydraulic infusion pump and polygraph.(18)
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Fig.1
Fig.2
Hydraulic infusion pump
The infusion pump perfuses the catheter at a constant rate and
pressure.
When the individual catheter orifices are occluded (either by a
contracting.
LOS or a wave in the oesophageal body), the pressure in the water
filled tube rises and this is recorded by the external transducers.(19)
11
External transducer
This pressure information is converted to an electrical signal by the
transducer and displayed on a dedicated computer monitor Computer
with software : to analyse data.
Fig.3
Fig.4
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AIM OF THE STUDY
To study the Esophageal Motility changes following Endoscopic
Variceal Band Ligation or Sclerotherapy using High resolution
Manometry.
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REVIEW OF LITERATURE
Early changes in Esophageal motility  Nitin M Narwanwe et al(20)
This study was done using water perfusion manometry in patients
with portal hypertension without ascites 24 hrs following two sessions of
Endoscopic variceal Band ligation/Endoscopic sclerotherapy
Manometry was done to measure the LES pressure, amplitude of
contraction in 10cms and 5cms of lower Esophagus .
Dysmotility was defined as presence of any one of the following .
 High amplitude contractions in the lower segment of the
Esophagus, simultaneous peristaltic  contractions, hypotensive <20mmhg
contractions.
Conclusion:
There were dysmotility changes following EST/EVL 24 hrs after
endotherapy and it was pronounced after the second session.
These dysmotilty changes did not produce any symtoms in the
patients.
What we derive from this study ?
Early changes following Endoscopic sclerotherapy and Endoscopic
Variceal Band Ligation can be due to Esophageal inflammation which
14
is  more  profund  after  24hrs  and  inflammation  can   be  more  after  2
sessions.(35)
Sequential esophageal motility studies after endoscopic injection
sclerotherapy: a prospective investigation.(21)
Grande L, Planas R, Lacima G, Boix J, Ros E, Esteve M, Morillas R,
Gasulle et al...
This study was done in 13 cirrhotic patients using water perfusion
manometry 24hrs following endoscopic variceal sclerosis and 4 weeks
following the endoscopic variceal sclerosis.
The observation of the study was the amplitude of contractions
were reduced  in the lower segment of the Esophagus and simultaneous
persitaltic contractions were  observed 24hrs after the procedure but these
changes disappeared 4weeks later.
Conclusion of the study was
Dysmotility changes do occur after Endoscopic Variceal  Sclerosis
but these changes do not interfere with motor transport of the esophagus.
Dysmotility changes are reversible.
After review of these two articles the questions are
Dysmotility of the esophagus following EST /EVL are due
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1. Esophageal inflammation following injection of Scleroscants and
or Variceal Band Ligation?
2. Are these changes reversible if it is due to inflammation?
3. The changes are reversible which suggests strongly that
inflammation has reduced after 4 weeks  or there is early
remodelling of Esophageal injury that has lead to the
reversiblity of the Dysmotility changes.
Can Dysmotility be a late complication ?
If so does it show Histological changes causing Fibrosis ?
Further search of Literature Review was done to look for late
complications following EST /EVL(26)
Histologic and Manometric Studies on the Esophagus Following
Endoscopic Sclerotherapy.
[My paper]Peeyush Sharma, Inga Hagerstrand, Dave Sharma
This study was done in patients who underwent endoscopic
sclerotherapy and or surgery for portal hypertension. The study was done
2-12 yrs after EST/surgery,
The histologic findings were done by taking biopsy in the lower
esophagus. It showed chronic inflammatory changes
16
The authors concluded that dysmotility occurring as a late
complication due chronic persistent inflammatory changes due to
Endoscopic Variceal Sclerotherapy.
Long-term effects of repeated injection sclerotherapy on esophageal
motility and mucosa. (24)
[My paper]B Isaksson, F Johnsson, B Jeppsson
Department of Surgery, Lund University Hospital, S-221 85 Lund,
Sweden.
Long-Term pH and Manometric Evaluation of the Distal Esophagus
After Endoscopic Sclerotherapy of Esophageal Varices
Mario Costantini1, Giovanni Zaninotto1
Neurogastroenterology & Motility(22)
This study was done in 21 patients to assess manometric changes
following endoscopic sclerotherapy. The authors concluded that
endoscopic sclerotherapy had significant structural changes but did not
cause significant gastroesophageal reflux.
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Esophageal motility changes after endoscopic intravariceal
sclerotherapy with absolute alchohol.
U C Ghoshal et al(23)
This study was conducted in 24 patients after endoscopic
sclerotherapy using Absolute alchohol.
This study shows frequent occurrence of esophageal dysmotility
after EST with AA; however, esophageal dysmotility after EST was
infrequently associated with motor dysphagia
Are there any other confounding factors which would contribute ot
these motility changes.
The two main confounding factors are Alchohol and presence of
Ascites in these patients
High amplitude contractions in the middle third of the oesophagus: a
manometric marker of chronic alcoholism?(25)
23 Chronic alcoholic patients underwent manometry . They were
compared  with Age matched controls
Conclusion of the above study:
Oesophageal peristaltic dysfunction and reflux are frequent in
alcoholism.
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High amplitude contractions in the middle third of the oesophagus
seem  to  be  a  marker  of  excessive  alcohol  consumption,  and  tend  to
improve with abstinence.
Lower Esophageal Sphincter Pressure in Cirrhotic Men with Ascites:
before and after diuresis.(27)
Lower Esophageal sphincter pressure (LESP) was measured in 10
biopsy-proved cirrhotics with esophageal varices and tense ascites before
and after diuresis to evaluate of ascites might play in the development of
variceal bleeding.
This study show motility changes in mid esophagus and LES
relaxation pressure.
Conclusion: Elevated intraabdominal pressure due to ascites caused
significant motility changes and LES pressure changes.
After analysis of these literature review
It is well documented that Endoscopic therapy both Endoscopic
Variceal Band Ligation and Endoscopic Variceal Sclerotherapy affects
the Esophageal motility.
These changes could be Early due to inflammation of the
Esophagus which is reversible
19
Long term effects causing Motility changes are due fibrosis though
does not produce any symptoms like dysphagia
There are confounding factors like changes produce by effect of
Alchohol per se.
Ascites causing elevated intraabdominal pressure do cause motility
changes of Esophagus?
What  are  the  parameters  of  manometric  findings   which  are
affected due  Endoscopic Sclerotherapy?
Does these motility changes cause symptoms like Dysphagia?
This study was designed to evaluate changes in motility of the
Esophagus using High Resolution Manometry in patient who have
undergone Endoscopic Variceal Band Ligation and Endoscopic
Sclerotherapy
This study was designed to be a prospective study done six month
after the Endoscopic procedures.
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MATERIAL AND METHODS
Study Design :   Prospective study
Total no.of subjects  :   20
Patients who were diagnosed to have portal hypertension who were
referred to the department of Gastroenterology at Madras Medical
College Hospital were included in this study
The diagnosis of portal hypertension and its etiology was
established by Clinical Biochemical Imaging and Histology if needed
An informed consent was obtained from these patients,
A baseline Esophageal Manometry is done for these patients using
High Resolution Manometry
Depending on the clinical situations these patients were subjected
to Endoscopic Variceal Sclerotherapy and or Variceal Band Ligation.
Endotherapy:
Endoscopic Variceal Sclerotherapy was done using Sclerotherapy
Needle (Indoinvasive Needle) using AOHUA Endoscopic Control
System Model VME2000 serial no 5208880
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The agent used was Injection polidoconal 3% diluted to 1.5%.
Both intra variceal as well as paravariceal injection were given
Ooze was controlled with scope tamponade
Endoscopic variceal Band Ligation:
Endoscopic Variceal Band ligation was done using multiband
Ligator (Variclear Multiband Ligator 6 preloaded Bands ,catheter and
irrigation adaptor.
Details such as amount of sclerosant injected, Number of sessions,
Number of Bands applied complications if any were collected
The patients were asked to come after six months . Their symptoms
were reviwed.
 Esophageal Manometry was repeated after six month using High
Resolution Manometry.
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High Resolution Manometry:
Equipment:
Water perfusion manometric system
Geoff Habbard systems, Royal Melbourne, Australia
16 lumen catheter
Dataware Trace 1.2 V software (Geoff Habbard systems, Royal
Melbourne, Australia)
High Resolution Manometry Procedure:
1. Subjects were instructed to come after an over night fast to reduce
the risk of aspiration during intubation.
2. History about any medication taken 48 hours prior to the test, to
exclude medication (prokinetic drugs, nitrates, anticholinergics,
Calcium channel blocker or sedatives) which will influence the
oesophageal  motility.
3. Dentures  (if any) were asked to be removed
4. The catheter lumens were prefilled with sterile water and the
lumens were capped to retain the fluid, which also helped to
prevent saliva and food debris from filling the lumens.
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5. Intubation was in supine position Trans nasal without topical
anesthesia
6. The catheter was inserted sufficiently, so that there were no
pressure measuring ports covering at least 10 cm of the stomach i.e
when the 50 cm mark on the tube was at the tip of the nose.
7. Catheter  is  positioned  and  the  subject  is  asked  to  lie  down
relaxedly
8. The catheter was connected to the transducers and infusion
commenced.
9. A period of at least 10 minutes were allowed for stabilization of the
subject's state and the recording system.
10. The infusion  pump was turned on with a transfusion rate of 0.6 ml
/ minute.
11. The subject's name, age, sex, hospital number and the date were
entered in the computer
12. Baseline LES was noted following 5 minutes of wet swallow
within an interval of 30 seconds between each swallow.
            Each 10 wet swallow phase includes Upper Esophageal
Relaxation, Body contour and    LES relaxation.
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Esophageal Body contour was clearly visualised by isobaric color
contour plot which provides continous depiction of pressure of entire
esophagus.
This allows complete spatio temporal analysis of esophageal
motion events.
Pressure in the esophagus is converted to an electrical signal by the
pressure transducer.
This signal is amplified and filtered then digitized using standard
circuit to the computer
Software will display, analyse data as a spatiotemporal plot against
both time and distance along the Esophagus.
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OBSERVATIONS & RESULTS
Total of Twenty patients were included in this study.
The age group of the patients were between 17-56 median of 36.6
yrs
No. of females : 16
No. of males : 4
TABLE - 1
MULTI VARIATE ANALYSIS OF DATA (Table:1)
VARIABLES No. of patients
Age 17-56 (36.5)
Sex
MALE 4
FEMALE 16
Etiology of Portal Hypertension
CLD 9
EHPVO 6
NCPF 5
Endoscopic therapy
EST 12
EVL 4
BOTH 4
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FIG 5. SHOWS THE DISTRIBUTION PATTERN OF DIEASES
CAUSING PORTAL HYPERTENSION.
MAJORITY WAS CHRONIC LIVER DISEASE, FOLLOWED BY
NCPF AND EHPVO
27
Fig 6:
Mode of Endoscopy Therapy EST:13 EVL:4 Both :4.
Majority of the Patients were subjected to Endoscopic
Scelerotherapy.
Four patients underwent EVL & Some Patients under went both
EVL & EST
28
High Resolution Manometry
BASELINE MANOMETRIC FINDINGS:
The Manometry was done for all patients before they were
subjected to Endotherapy, the findings are recorded in terms of Changes
in Amplitude (mm/hg) Length in mm & Velocity (mms/sec).
UPPER ESOPHAGUS (Table:2)
TABLE : 2
Variables N Mean Std. Dev P-Value
Length BL UE 20 58.05 5.66
Length 6M UE 20 60.02 8.39
0.239
Amplitude BL UE 20 49.55 7.33
Amplitude 6M UE 20 52.73 10.32
0.053
Velocity BL UE 20 34.50 9.03
Velocity 6M UE 20 33.73 9.21
0.564
These are the  Manometeric finding before & after Endotherapy in
the Upper Esophagus.
There are no significant changes in the upper Esophagus following
Endotherapy.
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MANOMETRIC CHANGES AFTER DIFFERENT MODES OF
ENDOTHERAPY:
Upper Esophagus (Table:3)
TABLE: 3
Therapy N Mean Std. Dev P-Value
Length BL UE 13 56.80 5.19
Length 6M UE 13 56.90 7.89
0.965
Amplitude BL UE 13 50.50 7.03
Amplitude 6M UE 13 54.56 11.02
0.097
Velocity BL UE 13 36.04 10.22
EST
Velocity 6M UE 13 33.85 10.13
0.214
Length BL UE 3 58.42 6.82
Length 6M UE 3 64.34 4.62
0.056
Amplitude BL UE 3 50.64 11.61
Amplitude 6M UE 3 50.99 11.56
0.790
Velocity BL UE 3 36.51 4.84
EVL
Velocity 6M UE 3 36.20 9.64
0.941
Length BL UE 4 61.82 6.20
Length 6M UE 4 66.92 7.65
0.053
Amplitude BL UE 4 45.67 5.25
Amplitude 6M UE 4 48.07 7.29
0.349
Velocity BL UE 4 27.99 3.52
Both
Velocity 6M UE 4 31.47 7.18
0.160
There is no Significant changes in the Amplitude (mm/hg), Length
in mm & Velocity (cms/sec) of the Upper Esophagus following
Endotherapy in comparison to different modes of endotherapy(Refer
chart 1).
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CHART : 1
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MANOMETRIC FINDINGS OF MIDDLE ESOPHAGUS
Baseline & after 6months:
MIDDLE ESOPHAGUS (Table:4)
TABLE : 4
Variables N Mean Std. Dev P-Value
Length BL ME 20 66.72 9.00
Length 6M ME 20 64.07 8.53
0.070
Amplitude BL ME 20 54.81 18.48
Amplitude 6M ME 20 69.94 5.92
0.302
Velocity BL ME 20 32.09 5.60
Velocity 6M ME 20 33.75 7.97
0.170
Table 4 follows Baseline Manometric findings of Middle
Esophagus in terms of Length (mm), Amplitude(mm/hg) & Velocity
(mms/sec).
There was no significant changes 6 months after Endotherapy
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Manometric changes after different modes of endotherapy – Middle
Esophagus
TABLE: 5
Therapy N Mean Std. Dev P-Value
Length BL ME 13 65.40 9.88
Length 6M ME 13 63.26 8.70
0.282
Amplitude BL ME 13 53.89 15.96
Amplitude 6M ME 13 71.85 73.70
0.426
Velocity BL ME 13 32.89 5.43
EST
Velocity 6M ME 13 35.77 6.61
0.029
Length BL ME 3 68.41 8.76
Length 6M ME 3 63.63 13.90
0.279
Amplitude BL ME 3 54.14 29.56
Amplitude 6M ME 3 71.27 8.71
0.481
Velocity BL ME 3 29.99 5.81
EVL
Velocity 6M ME 3 23.56 1.38
0.129
Length BL ME 4 69.74 6.98
Length 6M ME 4 67.02 3.75
0.376
Amplitude BL ME 4 58.28 23.25
Amplitude 6M ME 4 62.75 17.71
0.410
Velocity BL ME 4 31.10 7.05
Both
Velocity 6M ME 4 34.86 10.13
0.097
There is no Significant changes in the  Amplitude (mm/hg), Length
(mm) of the Middle Esophagus following Endotherapy.(Chart 2)
There is a significant change an increase in velocity following
Endoscopic sclerotherapy six months after the procedure.
33
CHART : 2
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MANOMETRIC FINDINGS OF LOWER ESOPHAGUS:
Baseline & after 6 months
TABLE : 6
Variables N Mean Std. Dev P-Value
Length BL LE 20 52.60 7.85
Length 6M LE 20 47.27 11.42
0.098
Amplitude BL LE 20 77.82 15.79
Amplitude 6M LE 20 55.15 21.74
?0.001
Velocity BL LE 20 28.95 5.39
Velocity 6M LE 20 24.09 4.86
0.010
Table 6 follows Baseline Manometric findings of Lower
Esophagus in terms of Length (mm), Amplitude(mm/hg) & Velocity
(mms/sec)
There is a significant changes in the amplitude and velocity of
contraction 6 months after Endoscopic Sclerotherapy (p value <0,001)
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Fig.7a
Fig.7b
Fig. 7a shows the tracings before the procedure – Baseline
Fig.7b shows the post procedure tracings which shows reduction in
amplitude of contractions in the lower esophagus.
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Fig. 8a
Fig. 8b
Fig. 8aShows baseline manometric finding in a patient before EST
Fig. 8b Shows decreased amplitude in a patient ager EST
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MANOMETRIC CHANGES IN LOWER ESOPHAGUS AFTER
DIFFERENT MODES OF ENDOTHERAPY:
TABLE: 7
Therapy N Mean Std. Dev P-Value
Length BL LE 13 53.61 9.47
Length 6M LE 13 48.10 12.25
0.225
Amplitude BL LE 13 76.56 17.85
Amplitude 6M LE 13 53.81 24.15
<0.001
Velocity BL LE 13 28.87 4.64
EST
Velocity 6M LE 13 23.61 5.55
0.001
Length BL LE 3 48.50 0.81
Length 6M LE 3 41.48 14.71
0.476
Amplitude BL LE 3 74.88 5.44
Amplitude 6M LE 3 51.77 14.57
0.142
Velocity BL LE 3 23.57 6.45
EVL
Velocity 6M LE 3 24.57 5.59
0.874
Length BL LE 4 52.37 3.09
Length 6M LE 4 48.91 6.48
0.512
Amplitude BL LE 4 84.13 14.72
Amplitude 6M LE 4 62.03 20.91
0.051
Velocity BL LE 4 33.26 4.04
Both
Velocity 6M LE 4 25.30 1.50
0.029
Table7 shows Following Endotherapy Manometric changes in
Lower Esophagus:
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EST Group:
Significant changes occurred in the Amplitude of contraction P
Value <0.001 & Velocity of contraction P Value 0.001  of  the  Lower
Esophagus following Endotherapy.
EVL Group:
There are no changes in Amplitude & Velocity in EVL Group.
Both EST & EVL Group:
There was Significant change in Amplitude P Value 0.05 &
Velocity P Value 0.029 in patients who underwent Both EST & EVL
However no changes were seen in the Length of the Lower
Esophagus in any of the Group.
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Fig. 9a
Fig. 9b
Fig. 9a shows baseline manometry pre procedure
Fig. 9b shows (EST & EVL group) tracings in a patient which
shows decreased in the amplitude in the amplitude of contraction.
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Chart : 3
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LES Pressure Baseline and after 6 Months: (Table:9)
Variables N Mean Std. Dev P-Value
LES Pressure BL 20 21.92 3.92
LES Pressure 6m 20 24.66 3.61
0.061
Table  9  shows  There  is  significant  changes  in  the  LES  Pressure
after Endotherapy
LES Pressure Changes Difference in Endotherapy (Table10)
Therapy N Mean Std. Dev P-Value
LES Pressure BL 13 23.05 3.81
EST
LES Pressure 6m 13 24.76 3.40
0.191
LES Pressure BL 3 21.48 3.82
EVL
LES Pressure 6m 3 27.56 3.91
0.191
LES Pressure BL 4 18.58 2.95
Both
LES Pressure 6m 4 22.15 3.05
0.067
Table10 shows Changes in LES Pressure in the Group were Both
EST & EVL were performed.
There is no significant changes  in LES  pressure in Both EST and
EVL group 6 months after therapy
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CHART : 4
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MANOMETERIC CHANGES IN THE UPPER ESOPHAGUS
AFTER ENDOTHERAPY – CORRELATIONS AFTER NO.OF
SESSIONS
TABLE : 11
No. of Session N Mean Std. Dev P-Value
Length BL UE 12 57.31 6.04
Length 6M UE 12 60.29 6.94
0.198
Amplitude BL UE 12 50.02 7.74
Amplitude 6M UE 12 51.79 10.16
0.195
Velocity BL UE 12 37.89 10.10
1
Velocity 6M UE 12 36.29 9.97
0.363
Length BL UE 5 58.30 2.62
Length 6M UE 5 58.02 10.89
0.947
Amplitude BL UE 5 46.62 3.82
Amplitude 6M UE 5 53.08 13.26
0.301
Velocity BL UE 5 30.04 3.35
2
Velocity 6M UE 5 29.68 8.13
0.925
Length BL UE 3 60.56 8.81
Length 6M UE 3 62.28 12.20
0.561
Amplitude BL UE 3 52.57 10.75
Amplitude 6M UE 3 55.91 8.47
0.145
Velocity BL UE 3 28.40 4.19
3
Velocity 6M UE 3 30.21 5.24
0.199
There is no Significant changes in Upper Esophagus following
Endotherapy correlation against no. of sessions.
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MANOMETERIC CHANGES IN THE MIDDLE ESOPHAGUS
AFTER ENDOTHERAPY – CORRELATIONS AFTER NO.OF
SESSIONS
TABLE : 12
No. of Session N Mean Std. Dev P-Value
Length BL ME 12 66.86 10.63
Length 6M ME 12 64.21 10.22
0.208
Amplitude BL ME 12 56.21 16.26
Amplitude 6M ME 12 82.40 73.67
0.287
Velocity BL ME 12 31.49 5.51
1
Velocity 6M ME 12 31.92 7.61
0.811
Length BL ME 5 66.41 6.66
Length 6M ME 5 63.99 4.22
0.490
Amplitude BL ME 5 64.05 19.81
Amplitude 6M ME 5 59.41 17.08
0.596
Velocity BL ME 5 30.22 3.96
2
Velocity 6M ME 5 32.02 4.15
0.058
Length BL ME 3 66.67 7.66
Length 6M ME 3 63.62 8.97
0.065
Amplitude BL ME 3 33.76 10.72
Amplitude 6M ME 3 37.70 8.05
0.172
Velocity BL ME 3 37.65 6.50
3
Velocity 6M ME 3 43.98 8.06
0.025
There is no significant changes in Middle Esophagus against
correlation against number of sessions of Endotherapy
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MANOMETERIC CHANGES IN THE LOWER ESOPHAGUS
AFTER ENDOTHERAPY – CORRELATIONS AFTER NO.OF
SESSIONS
TABLE : 13
No. of Session N Mean Std. Dev P-Value
Length BL LE 12 53.61 7.84
Length 6M LE 12 44.71 11.83
0.060
Amplitude BL LE 12 80.19 15.14
Amplitude 6M LE 12 56.90 22.59
0.001
Velocity BL LE 12 27.17 5.27
1
Velocity 6M LE 12 24.08 5.23
0.115
Length BL LE 5 53.15 8.18
Length 6M LE 5 50.84 12.69
0.812
Amplitude BL LE 5 82.76 16.03
Amplitude 6M LE 5 64.27 18.92
0.021
Velocity BL LE 5 33.42 4.31
2
Velocity 6M LE 5 24.88 5.12
0.010
Length BL LE 3 47.61 8.36
Length 6M LE 3 51.53 7.08
0.669
Amplitude BL LE 3 60.14 5.60
Amplitude 6M LE 3 32.94 1.48
0.021
Velocity BL LE 3 28.65 4.11
3
Velocity 6M LE 3 22.80 4.17
0.029
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There are  significant changes in Amplitude of contraction of the
Lower Esophagus following Endotherapy correlation against no.of
sessions. The amplitude of contraction decreases in the first session,
second session and third session
There is a change in velocity following second and third session of
endotherapy.
Fig. 10
Fig. 10 shows decreased amplitude of contraction of contraction in
the lower esophagus in post EST paint after 2 sessous  of endoviraty.
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LES PRESSURE CHANGES AFTER ENDOTHERAPY
CORRELATION AGAINST NO.OF SESSION:
TABLE : 14
No. of Session N Mean Std. Dev P-Value
LES Pressure BL 12 22.95 3.91
1
LES Pressure 6m 12 25.50 3.39
0.065
LES Pressure BL 5 21.78 3.15
2
LES Pressure 6m 5 23.58 4.10
0.439
LES Pressure BL 3 18.07 3.65
3
LES Pressure 6m 3 23.08 4.01
0.202
There no significant changes in LES Pressure correlated against
no.of sessions
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ANALYSIS
Paired samples T-Test to compare mean values between baseline
and 6 months
Stastical analysis was done using  SPSS version 1.7
P value of <0.05 is statistically significant
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DISCUSSION
Endoscopic Variceal  Sclerotherapy and Endoscopic Variceal Band
ligation is the standard of care in the management of Variceal Bleed.
Dysmotility is a known complication of Endotherapy.
Dysmotility of Esophagus can be early  or late complication.
This study was done six months after Endoscopic Sclerotherapy
and or Endoscopic Variceal Band Ligation to look for any dysmotility
following Endotherapy occurring as a late complication.
The patients included in this study was patients in whom the
etiology of portal hypertension  was Chronic liver disease of Non
Alcoholic etiology, Non cirrhotic portal fibrosis and Extra hepatic portal
hypertension.
This study was done using injection Polidoconal 3%-1.5% both
intra variceal and  Paravariceal as against the previous studies Narwane et
al and UC Ghoshal etal were done using  Absolute Alcohol  and Phenol
in water.
Two confounding variables like Alcohol and Ascites were
excluded from this study.
Alcoholic Liver disease were excluded from  this disease.
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Alcohol per se can cause changes in Manometry causing High
Amplitude contractions in the middle Esophagus and these changes
disappeared after abstaining from Alcohol Grande ,et al.(26)
Ascites causes changes in the LES pressure Van Thiel DH,
Stremple JF(38)
Dysmotility  of  the  Esophagus  occurs  as  a  late  complication.  This
could be due to fibrosis at the site of Endoscopic Variceal Sclerotherapy
and Endoscopic Variceal Band Ligation  causing focal segmental motility
changes
Following Endoscopic intravariceal Sclerotherapy the
inflammatory changes are persistent which causes dysmotility in the
lower esophagus
This is supported by the study by a study by Peeyush Sharma et al
A Study on Histologic and Manometric Studies on the Esophagus
Following Endoscopic Sclerotherapy.
[My paper]This study was done in forty six patients who have
undergone Endoscopic intravariceal sclerotherapy and or Surgery.
This study was a follow up period of 2-12 yrs after the endoscopic
intraviceal sclerotherapy . There was a significant change in the lower
esophagus where the amplitude of contraction decreased following
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intravariceal Sclerotherapy.. Mucosal biopsy was taken in duplicate from
the distal esophagus which showed chornic inflammatory changes in the
lower esophagus. The persistent abnormalities in the esophagus was,due
to chronic inflammatory changes  in the distal esophagus.
This study was done using High Resolution Manometry which uses
pressure sensors placed at interval of < 2cm which will be able to detect
focal segment motility changes.(49)
This is the advantage of High Resolution Manometry over
Conventional Manometry(43)
The following parameters were studied  using High Resolution
Manometry
Amplitude of contraction(mm/hg)
Velocity of contraction(mm/sec)
Length (mms)
LES pressure(mm/hg)
Presence of any Non peristaltic waves
These changes were  recorded in the Upper, Middle & Lower
Esophagus.as against a study by Nitin Narwane et al(34) titled
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 Early  changes in the motility of esophagus following Endoscopic
Variceal sclerotherapy and Variceal Band Ligation changes following
Endoscopic Variceal Sclerotherapy
The manometric changes were recorded in distal esophagus 5 cms
and 10cms from LES.
This could be revelant in the context of transition zone of the
Esophagus which occurs 8cms above the LES. The velocity of
contraction reduces in this transition zone.
Narwane Et al Indian J Gastroenterology 1998.(40)
Manometric parameters:
A Baseline Manometry was done for all patients. Patient with
abnormal Baseline parameters were excluded from this study.
In this study there were no significant changes in Amplitude
,velocity of contraction, and length  in the upper& middle Esophagus.
There were Manometric changes in the Lower Esophagus
Manometric changes in Lower Esophagus are:
There was a significant decrease in the amplitude of contraction
and velocity of contraction in the lower Esophagus. A mean value of
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77.82 reduced by 55.15 mmHg in 6months following endotherapy p value
<0.001
Esophageal motility changes after endoscopic intravariceal
sclerotherapy with absolute alcohol
U C Ghoshal et al. In this study there was a significant reduction in
the amplitude of contraction of the lower Esophagus  (63.4 ± 24.9 vs.
18.2  ±  14.3  mmHg    and  the  duration  of  the  peristaltic  wave  was
prolonged in both middle and lower esophagus.(23)
Sequential Esophageal motility changes after Endoscopic injection
sclerotherapy- by Granade etal(37)
In this  study there was a significant  decrease  in the amplitude of
contraction of the lower Esophagus
While assessing the question of whether the mode of therapy
intravariceal Sclerotherapy or  Endoscopic Variceal Band Ligation affect
the motility changes of the Esophagus there was a significant decrease in
the amplitude of contraction and velocity of contraction in the EST group
rather than Endoscopic Variceal Band Ligation group
This  is  compared  to  the  study  by Geoff  et  al  which  showed that
there was no significant change in motility pattern of the esophagus
following Endoscopic Variceal Band Ligation.(36)
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Manometric changes following EST/EVL correlation with Number of
sessions
In this study there was a reduction in velocity of the middle
esophagus when they underwent three sessions  and both Endoscopic
Variceal BandLligation and endoscopic Sclerotherapy.
In the lower Esophagus in the EST group there was  a significant
change even after the first session
But in a group of patients who underwent both EST and EVL there
was reduction in velocity of contraction following three times after
therapy
Peeyush et al study shows that there the number of session
scorrelated with the manometric abnormalities and not the amount of
sclerosant injected.(25)
LES pressure :
In  this  study  there  was  no  change  in  the  LES  pressure  following
endotherapy.
The  LES  pressure  did  not  differ  between  the  groups  of
Sclerotherapy and.Endoscopic Variceal Band Ligation.
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But however there was a fall in the LES pressure when the Number
of sessions increased in both therapy group.
UC Ghosal et al have shown a reduction in the LES pressure
following Endoscopic sclerotherapy(42)
Sauerbruch T, Wirsching et al did Esophageal functional
scintigraphy which showed reduction in the LES pressure(22(30.5 +/- 17.5
mm Hg versus 43.6 +/- 9.1 mm Hg, p less than 0.01)
Mario  Costantini   et  al  study  did  not  show  any  reduction  in  LES
pressure but it affected the LES relaxation pressure which impairs the
bolus clearance causing retrosternal pain and dysphagia(28)
In this study there were no abnormal waves . there was no change
in the length of the  Esophagus and no abnormalities in the duration of the
waves
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CONCLUSION
Endosocpic  Sclerotherapy and Endoscopic Variceal Band Ligation
causes Dysmotility
Dysmotility can occur a late complication due to persistent chronic
inflammatory changes
High Resolution Manometry is a Novel method to identify focal
segmental changes  in motility following Endoscopic Sclerotherapy and
Endoscopic Variceal Band Ligation
In this study there was manometric changes in the form of
decreased amplitude and velocity of contraction in the Lower Esophagus
The motility changes were more commonly found in the
Endoscopic sclerotherapy group.
Though in our study the two groups were not comparable in
number
The number of sessions did not correlate with the Endoscopic
Sclerotherapy group but in a group of patient who underwent both
therapy they developed motility changes after third session
In  this  study  there  were  no  abnormal  waves  and   Non  peristaltic
waves, no prolongation of duration of peristaltic waves  .
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None of these patients had any symptoms.
Endoscopic variceal sclerotherapy causes Esophageal motility
changes six months after therapy.
There was no motility changes following Endoscopic Variceal
Band Ligation alone was used.
These changes do not causes any dysmotility symptoms in patients.
PATIENT CONSENT FORM
Study Details  : A study of Esophageal Motility  changes following Endoscopic
                                   Variceal Band Ligation or Sclerotherapy using High Resolution
                                   Manometry.
Study Centre : Department of Gastroenterology,
           Madras Medical college, Chennai.
Patient may check (/) these boxes
I confirm that I have understood the purpose of procedure for the above study. I have
the opportunity to ask question and all my questions and doubts have been answered
to my complete satisfaction.
I  understand  that  my  participation  in  the  study  is  voluntary  and  that  I  am  free  to
withdraw at any time without giving reason, without my legal rights being affected.
I understand that sponsor of the clinical study, others working on the sponsor’s behalf,
the ethical committee and the regulatory authorities will not need my permission to
look  at  my health  records,  both  in  respect  of  current  study  and  any  further  research
that may be conducted in relation to it,  even if  I  withdraw from the study I  agree to
this access. However, I understand that my identity will not be revealed in any
information released to third parties or published, unless as required under the law. I
agree not to restrict the use of any data or results that arise from this study.
I agree to take part in the above study and to comply with the instructions given
during the study and faithfully cooperate with the study team and to immediately
inform the study staff if I suffer from any deterioration in my health or well being or
any unexpected or unusual symptoms.
I hereby give permission to undergo complete clinical examination and diagnostic
tests including hematological, biochemical, radiological tests.
I hereby consent to participate in this study.
Signature / thump Impression
Patient Name and Address: Place Date
Signature of Investigator
Study Investigator’s Name: Place Date
INFORMATION SHEET
? We are conducting an Prospective “Study on Esophageal motility changes
following Endoscopic  Variceal Band Ligation or Sclerotherapy using High
Resolution Manometry.” at Department of Gastroenterology, Madras Medical College
and Government General Hospital, Chennai.
? The purpose of the study is to evaluate the
Esophageal motility changes following Endoscopic Variceal Sclerotherapy /
Endoscopic Variceal Band Ligation which is the standard of care for the management
of Portal Hypertensive  Upper GI Bleed. These motility changes will be studied using
High Resolution Manometry six  months following the therapy.
? Taking  part  in  this  study  is  voluntary.  You  are  free  to  decide  whether  to
participate in this study or to withdraw at any time;  your decision will not result in
any loss of benefits to which you are otherwise entitled.
? The  results  of  the  special  study  may  be  intimated   to  you  at  the  end  of  the
study period or during the study if anything is found abnormal which may aid in the
management or treatment.
Signature of investigator Signature of participant
Date:
PROFORMA
Name :
Age :
Sex :
Occupation :
Address :
Contact No. :
Chief complaints:
H/O  Presenting illness:
Onset:
Duration:
Amount of  UGI Bleed
Associated Symptoms
1. Adb. Pain
2. Abd. Distension
3. Swelling of legs
4. H/O Jaundice.
5. Loss of Appetite
6. Difficulty in Swallowing
7. H/O hold-up, regurgitation
8. Urine Output
9. Bowel Habits
PAST HISTORY
Previous H/O UGI Bleed DM/HTN/TB/BA/IHD/CVA/EPILEPSY
Post H/O Jaundice
H/o  Sex , surgery/Jaundice/ Transfusion / Tatooting
H/o Umbilical sepsis / catheherisation
Treatment users
Nature of Treatment
Endoscopic Treatment
EST EVL Both
EXAMINATION
Pallor/cyanosis/ Clubbing/ Pedal edema/ Raised/ JVP/ Icterus/
Lymphadenopathy.
Ht. Wt. BMI:
Oral    Cavity
Adbomen Examination
Inspection:
Palpation:
Percussion:
Auscultation:
Per rectal Examination:
TREATMENT GIVEN
EST
Agent:
Total CC:
IV/PV:
Conquest
No. of Sessions
EVL
No. of   Bands applied
Complications  if any:
INVESTIGATIONS
CBC:
Hb:
TC:
DC:
ESR:
PLT:
Peripheral smear:
RFT: Urea
Creatinine:
Urine routine
Motion routine
CXR:
ECG:
USG ABDOMEN:
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L AMP VEL L AMP VEL L AMP VEL
LES
Pressure
L AMP VEL L AMP VEL L AMP VEL
1 GANESH 35 M NCPF * 1 50.17 54.14 50.26 58.53 41.79 29.38 60.09 64.65 27.47 22.21 60.44 58.33 48.77 56.56 42.33 29.56 59.88 61.66 25.26 20.16
2 SUMITHRA 27 F NCPF * 1 63.09 45.16 31.23 77.43 60.05 30.61 61.23 89.01 31.12 28.43 44.37 41.12 23.57 63.73 36.17 43.19 44.37 31.23 27.52 28.13
3 VIGNESH 17 M EHPO * 1 50.93 37.92 50.26 67.65 61.64 25.22 49.41 70.45 26.57 19.13 51.92 36.99 37.23 66.12 60.65 25.01 50.23 66.34 24.12 22.19
4 CHINNAPONNU 56 F CLD * 2 54.73 46.37 32.94 66.79 79.58 33.57 45.61 85.58 37.2 24.45 40.4 73.91 19.84 57.34 46.3 33.49 67.96 73.48 32.57 29.23
5* MALLIKA 45 F CLD * 1 50.93 50.22 33.41 66.89 58.43 38.9 63.09 74.45 27.39 27.1 59.03 58.22 34.13 68.96 54.83 38.9 53.21 42.15 19.12 27.1
6 LALITHA 33 F EHPO * 1 60.05 58.52 25.73 77.52 77.88 24.38 58.76 118.66 19.24 24.79 61.55 56.66 24.67 67.87 76.13 24.65 31.91 101.14 22.46 25.29
7 PRIYA 26 F EHPVO * * 2 60.17 50.22 26.24 63.85 77.88 29.56 52.3 85.1 36.12 22.13 67.01 56.12 27.64 62.35 72.18 33.58 46.37 75.11 24.76 24.16
*8 TAMILARASI 28 F NCPF * 2 60.17 45.16 31.05 60.05 39.74 34.14 66.89 56.86 30.1 25.15 58.17 46.51 31.05 66.05 38.15 36.23 34.96 31.01 18.15 19.2
9 MANILA 28 F NCPF * 1 50.93 37.92 38.23 67.65 61.14 25.22 49.41 70.45 16.53 17.1 59.03 39.27 32.38 65.76 61.64 22.25 58.33 66.65 24.17 28
10* VASANTHI 40 F CLD * 3 56.25 54.14 26.24 58.53 23.93 41.79 39.52 54.12 25.4 22.11 53.25 56.15 26.14 53.85 29.33 48.17 51.69 33.91 21.27 23
11 RAMAN 56 M CLD * 1 50.17 53.31 31.23 63.85 60.07 41.35 59.39 67.23 29.96 21 57.1 58.23 37.21 66.58 59.18 38.35 60.05 55.65 18.27 22
12* TAMILMARI 35 F CLD * 1 60.05 60.68 40.26 60.05 21.71 36.46 47.89 80.95 25 24.12 66.56 62.38 47.16 48.79 78.59 25 34.96 51.12 30.34 31.23
13 MASTHAN BEE 40 F CLD * 1 61.02 58.52 58.81 41.05 55.75 32.6 45.15 92.03 36.15 29 62.01 68.52 56.18 48.5 60.75 35.8 31.92 86.1 36.12 28
14* RAJANI 55 F CLD * 3 54.73 62.45 33.23 67.75 45.19 30.16 47.1 61.12 27.27 17.1 57.43 64.25 36.13 65.54 45.39 34.69 58.53 33.67 19.62 27.13
15 GUNA 26 F CLD * 1 63.09 45.16 31.23 77.43 60.04 30.61 61.23 89.01 31.12 18.23 69.03 48.26 36.23 83.45 72.15 38.61 48.61 62.12 22.21 28
16 PRIYADARSHINI 28 F EHPO * * 2 60.17 50.22 26.74 63.85 77.88 29.56 52.3 85.1 36.12 19.18 67.1 50.22 27.64 66.58 78.78 31.56 46.37 75.11 24.76 25.33
17 KAMATCHI 35 F NCPF * * 2 56.25 41.12 33.23 77.53 45.19 24.28 48.65 101.14 27.54 18 57.42 38.62 42.23 67.65 61.64 25.22 58.53 66.65 24.17 20
18* PARVEEN 35 F NCPF * 1 64.27 53.31 31.05 77.53 79.58 28.3 48.19 73.23 29.19 23.23 67.42 51.33 29.05 76.35 73.58 23.42 31.16 37.53 19.19 23.45
19* DHANALAKSHMI 43 F CLD * * 3 70.69 41.12 25.73 73.73 32.16 40.99 56.22 65.19 33.27 15 76.16 47.32 28.37 71.48 38.38 49.09 44.37 31.23 27.52 19.12
20* HASAN BASHA 19 M EHPO * 1 63.05 45.37 32.94 66.79 36.47 34.8 39.52 72.15 26.26 21 65.03 42.17 28.94 57.89 312.74 38.3 31.92 21.1 2O.19 22.4
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KEY WORDS
1. EST – Endoscopic Sclerotherapy
2. EVL – Endoscopic Variceal Band Ligation
3. 6M – Six months
4. BL – Base line
5. CLD – Chronic Liver Disease
6. NCPF – Non Cirrholic Portal Fibrosis
7. EHPVO  –  Extra Hepatic Portal Vein Obstruction.
